Control of experimental breast cancer by antioestrogenic therapies [proceedings].
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology; D000818:Animals; D002369:Castration; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D010053:Ovary / Q000502:physiology*; D051381:Rats; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen; D015127:9,10-Dimethyl-1,2-benzanthracene